Prefer in VTE Prevention of Thromboembolic Events – European Registry in Venous Thromboembolism
To assess the 12 month direct health care resource use and estimated costs following acute first-time (initial) or recurrent VTE
Multi –national, multi-centre, prospective observational disease registry
Dr Petra Laeis, Munich
Dr. Matt Reed
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.